Holen Sie sich die Stockscreener-App
11.62
1.94%
-0.23
Handel nachbörslich:
11.60
-0.02
-0.17%
Schlusskurs vom Vortag:
$11.85
Offen:
$11.86
24-Stunden-Volumen:
2.13M
Relative Volume:
0.79
Marktkapitalisierung:
$2.91B
Einnahmen:
$496.43M
Nettoeinkommen (Verlust:
$71.35M
KGV:
40.79
EPS:
0.2849
Netto-Cashflow:
$151.57M
1W Leistung:
+0.00%
1M Leistung:
-21.22%
6M Leistung:
-13.93%
1J Leistung:
-28.97%
1-Tages-Spanne:
$11.40
$11.97
1-Wochen-Bereich:
$11.40
$12.43
52-Wochen-Spanne:
$9.58
$19.98
Cellebrite Di Ltd Stock (CLBT) Company Profile
Firmenname
Cellebrite Di Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, FTNT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
11.62 | 2.84B | 496.43M | 71.35M | 151.57M | 0.2849 |
MSFT
Microsoft Corp
|
496.82 | 3.57T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
145.75 | 409.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
169.46 | 418.04B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
203.42 | 193.82B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
154.54 | 110.64B | 7.11B | 1.95B | 2.44B | 2.5883 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-28 | Bestätigt | Needham | Buy |
| 2024-03-13 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2021-12-02 | Eingeleitet | BofA Securities | Buy |
| 2021-10-21 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Cellebrite Di Ltd Aktie (CLBT) Neueste Nachrichten
Cellebrite (CLBT): CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains - Yahoo Finance
Kaplan Fox Launches Securities Probe into Cellebrite DI Ltd (CLBT) Following 29% Stock Plunge and CEO Replacement - Kalkine Media
Cellebrite DI Ltd (CLBT) Faces Securities Investigation After 29% Stock Drop and CEO Change - kalkine.ca
Cellebrite Genesis expands to UK & Australia - SourceSecurity.com
Cellebrite shares plunge over 30% after Q2 reve... - Pluang
Cellebrite DI Ltd. (CLBT) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Cellebrite Genesis AI Solutions Expand Globally | Security News - Security Informed
Cellebrite (CLBT) Q2 2026 Earnings Call Transcript - The Globe and Mail
Kaplan Fox Announces an Investigation Into Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global Markets - Japan Wire by Kyodo News
Cellebrite’s New CEO Resets 2026 Outlook After Record 2025 and Calls September Shareholder Meeting - The Globe and Mail
Cellebrite expands Genesis AI tool to enterprise market By Investing.com - Investing.com South Africa
Cellebrite faces securities probe after missing revenue targets and sudden CEO change. - Pluang
Cellebrite DI (CLBT) Stock Falls 29% After ARR Miss and CEO Change, Sparking Securities Investigation - kalkine.ca
Cellebrite DI Says Genesis Platform Now Available to Enterprises, Expands Globally - marketscreener.com
Cellebrite Di Ltd Cellebrite Genesis Is Expanding To More Global Markets And Is Now Generally Available For Enterprise Organizations - TradingView
Cellebrite expands Genesis platform to enterprise and new markets - StreetInsider
Cellebrite (CLBT) officer sets 2026 sell-to-cover for 5,673 shares - Stock Titan
Cellebrite (NASDAQ: CLBT) officer plans tax-driven share sale - Stock Titan
Cellebrite Genesis Expands to Global Markets - Intellectia AI
Cellebrite DI Ltd (CLBT) Stock News Today - TradingKey
Cellebrite (CLBT) Quarterly Figures: Profit Per Share Falls Below Its Benchmark in the Latest Reading; Reaction Snapshot: Shares Finish 5.36% Up at the ClosePre-Announcement Alert - Vinanet
Cellebrite Genesis Expands Internationally - Intellectia AI
Voss Capital reports new stake in Cellebrite (NASDAQ: CLBT) - Stock Titan
Cellebrite (NASDAQ: CLBT) lowers 2026 forecast amid vote on CEO equity plan - Stock Titan
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) to Possible Securities Law Violations - The National Law Review
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cellebrite DI Ltd. (CLBT) - GlobeNewswire
Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating - Yahoo Finance
Cellebrite DI Ltd. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:CLBT) 2026-08-17 - Seeking Alpha
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 6.2% Following Analyst Downgrade - MarketBeat
Why Cellebrite DI (CLBT) Is Down 30.4% After Cutting 2026 Outlook And Announcing CEO Transition - simplywall.st
Cellebrite DI Is Maintained at Buy by DA Davidson - Moomoo
Cellebrite DI Ltd (CLBT) Stock Up 3.1% and Still Undervalued -- GF Score: 84/100 - GuruFocus
Can Cellebrite DI (NASDAQ:CLBT) Regain Market Confidence? - Kalkine Media
Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools - simplywall.st
Cellebrite Announces CEO Transition to Shiven Ramji in Planned Succession - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Given New $15.00 Price Target at Lake Street Capital - MarketBeat
CLBT|Cellebrite DI Ltd|Price:11.110|Chg%:+0.310 - TradingKey
Cellebrite Plunges 29% as New CEO Ramji Slashes 2026 Revenue Outlook - finance.biggo.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Given New $16.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Legal Tech Roundup: Cellebrite, LexisNexis - Law360
Cellebrite DI (NASDAQ:CLBT) Sees Unusually-High Trading Volume After Strong Earnings - MarketBeat
DA Davidson Has Lowered Expectations for Cellebrite DI (NASDAQ:CLBT) Stock Price - MarketBeat
Cellebrite DI Ltd. (CLBT) Edges Higher on Steady Demand for Digital Intelligence SolutionsIchimoku Cloud - Vinanet
Cellebrite DI (CLBT) Cuts Guidance And Changes CEO, Is The Stock Now Cheap? - Yahoo Finance
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd. - PR Newswire
Cellebrite DI (NASDAQ:CLBT) Given New $12.50 Price Target at Needham & Company LLC - MarketBeat
Needham cuts Cellebrite stock price target on guidance reduction By Investing.com - Investing.com South Africa
Needham cuts Cellebrite stock price target on guidance reduction - Investing.com
Finanzdaten der Cellebrite Di Ltd-Aktie (CLBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cellebrite Di Ltd-Aktie (CLBT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GEE DAVID NICHOLAS | Chief Marketing Officer |
Aug 24 '26 |
Sale |
11.36 |
4,323 |
49,111 |
135,281 |
1.12%
5.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):